Development of a paediatric asthma shared decision-making tool: intervention design and evaluation

儿童哮喘共同决策工具的开发:干预设计与评估

阅读:1

Abstract

BACKGROUND: Asthma is the most common chronic disease in children, yet adherence to treatment remains poor due to barriers in communication and self-management. Shared decision-making (SDM) can improve adherence, but no decision aid currently exists for paediatric asthma. This gap limits children’s engagement in treatment decisions, highlighting the need for a tailored patient decision aid. The aim was to develop a decision aid to support SDM between children with asthma, their parents, and healthcare providers (HCPs), followed by an evaluation of its acceptability and usability. METHODS: A user-centred, iterative co-design approach was used, involving children aged 6–18 years with physician-diagnosed asthma, their parents, and healthcare providers (including paediatricians, asthma nurses, and general practitioners). An initial needs assessment identified key challenges in asthma-related decision-making. These insights informed eight structured co-creation sessions focusing on identifying decision points, exploring preferences, and shaping content and format of the decision aid. Usability and acceptability were tested with end-users, and the final version was independently reviewed against the IPDAS checklist by two researchers to assess quality and completeness. RESULTS: A needs assessment (n = 37) with HCPs, patients, and caregivers identified substantial information gaps, with many patients and parents unaware of treatment options or potential side effects. HCPs emphasised the potential value of a decision aid in improving information delivery and encouraging SDM. In eight co-creation sessions, a multidisciplinary group (n = 18) collaborated to develop and refine two complementary decision aids. Feedback highlighted improved clarity, age-appropriate design, and relevance for real-life consultations. In the final phases, both decision aids were tested for acceptability and usability, showing high user satisfaction with minor revisions made (n = 32). A quality assessment was conducted by two independent reviewers. Both tools met all 12 IPDAS criteria. These results confirm their quality and suitability for implementation in practice. CONCLUSION: The decision aids were well received by patients, parents and HCPs and met IPDAS criteria. They address critical unmet needs in paediatric asthma care by supporting informed decision-making. These tools have the potential to improve the quality of clinical consultations and promote more patient-centred care in the treatment of childhood asthma. CLINICAL TRIAL NUMBER: Not applicable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-025-03235-w.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。